Joel A Simon. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Clinical Trials as TopicCoronary Disease/bloodCoronary Disease/etiologyCoronary Disease/prevention & controlHumansHyperuricemia/bloodHyperuricemia/drug therapyMyocardial Infarction/prevention & controlPlatelet Aggregation Inhibitors/therapeutic useRandomized Controlled Trials as TopicRisk FactorsSulfinpyrazone/therapeutic useTreatment OutcomeUric Acid/bloodUricosuric Agents/therapeutic use
Substances： See more » Platelet Aggregation InhibitorsUricosuric AgentsUric AcidSulfinpyrazone
Year: 2006 PMID： 16564763 DOI： 10.1016/j.amjmed.2005.08.031
Source DB: PubMed Journal: Am J Med ISSN： 0002-9343 Impact factor: 4.965